UpTempo℠ AAV Platform Process Accelerates Time From Gene To Clinic

Ғылым және технология

Catalent's UpTempo AAV platform process offers clients accelerated timelines for producing their clinical materials. The scalable, CGMP-ready platform process can significantly reduce the time from gene to clinic through a simplified supply chain, increased development and manufacturing efficiencies, and standardized documentation.
Catalent. More products. Better treatments. Reliably supplied.™
Every molecule has a challenge.
We have a solution.
Contact Us: catalent.com/contact-us
Call: +1 888 SOLUTION
Visit: catalent.com

Пікірлер

    Келесі